Resource Center
Explore Resource Types
Focused Solutions
Biologics
Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.
Cell and Gene Therapy
The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.
Disease Research
New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.
Drug Development
The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.
Functional Genomic Screening
Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies
Integrated Lab Automation
From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations
Physiological Model Solutions
Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.
Precision Medicine Research
Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.
Small Molecule Drug Discovery
With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.
All Resources
Filters
241 - 252 of 1186 Results
Autophagy regulation eBook
Epigenetic modifications and how they relate to cancer development and therapy
Quantifying the degradation of RBM39 in Neuroblastoma cells treated with molecular glue degraders using HTRF technology
Research and characterization of bispecific antibodies for cancer immunotherapies
Simplify your 16S library prep and analysis.
Cerenkov Imaging of Radioisotopes in IVIS systems
Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment
Protein recycling, TPD, and neurodegenerative disease
An overview of atherosclerosis
Optimizing ternary complex assays with AlphaLISA Toolbox reagents for targeted protein degradation applications
Investigate mechanism of action of drugs targeting TDP-43 phosphorylation and aggregation with HTRF-based detection assays
Get your white paper about current therapies in Immuno-oncology
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.